Strategies for reducing polypharmacy in older adults

Journal of Gerontological Nursing

Volumn 36, Issue 1, 2010, Pages 8-12

  Planton, Jonathan ^a   Edlund, Barbara J ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; CASE REPORT; DRUG INTERACTION; DRUG MONITORING; EVIDENCE BASED PRACTICE; GERIATRIC ASSESSMENT; GERIATRIC NURSING; HUMAN; MALE; NURSING ASSESSMENT; ORGANIZATION AND MANAGEMENT; PATIENT CARE PLANNING; PATIENT SELECTION; POLYPHARMACY; RISK ASSESSMENT; SAFETY;

AGED; DRUG INTERACTIONS; DRUG MONITORING; EVIDENCE-BASED PRACTICE; GERIATRIC ASSESSMENT; GERIATRIC NURSING; HUMANS; MALE; NURSING ASSESSMENT; PATIENT CARE PLANNING; PATIENT SELECTION; POLYPHARMACY; RISK ASSESSMENT; SAFETY MANAGEMENT;

EID: 77955891542     PISSN: 00989134     EISSN: None     Source Type: Journal    
DOI: 10.3928/00989134-20091204-03     Document Type: Article

References (24)

1. Bair, M.J., Robinson, R.E., Katon, W., & Kroenke, K. (2003). Depression and pain comorbidty: A literature review. Archives of Internal Medicine, 163, 2433-2445.
2. Bliss, D.Z., Zehrer, C., Savik, K., Thayer, D., & Smith, G. (2006). Incontinence-associated skin damage in nursing home residents: A secondary analysis of a prospective, multicenter study. Ostomy/Wound Management, 52(12), 46-55.
3. Bootman, J.L., Harrison, D.L., & Cox, E. (1997). The health care cost of drug related morbidity and mortality in nursing facilities. Archives of Internal Medicine, 157, 2089-2096.
4. Bushardt, R.L., & Jones, K.W. (2005). Nine key questions to address polypharmacy in the elderly. Journal of the American Academy of Physician Assistants, 18(5), 32-37.
5. Cockcroft, D.W., & Gault, M.H. (1976). Predictions of creatinine clearance from serum creatinine. Nephron, 16, 31-41.
6. Egger, S.S., Bachmann, A., Hubmann, N., Schlinger, R.G., & Krähenbühl, S. (2006). Prevalence of potentially inappropriate medication use in elderly patients: Comparison between general medical and geriatric wards. Drugs & Aging, 23, 823-837.
7. Fadem, S.Z., & Rosenthal, B. (2009). CKD EPI & MDRD GFR calculator-(with SI units). Retrieved from the Nephron Information Center website: http://www.nephron.com/MDRD_GFR.cgi
8. Fick, D.M., Cooper, J.W., Wade, W.E., Waller, J.L., Maclean, J.R., & Beers, M.H. (2003). Updating the Beers criteria for potentially inappropriate medication use in older adults: Results of a US consensus panel of experts. Archives of Internal Medicine, 163, 2716-2724.
9. Field, T.S., Gurwitz, J.H., Harrold, L.R., Rathschild, J., De Bellis, K.R., Seger, P.A., et al. (2004). Risk factors for adverse drug events among older adults in the ambulatory setting. Journal of the American Geriatrics Society, 52, 1349-1354.
10. Fulton, M.M., & Allen, E.R. (2005). Polypharmacy in the elderly: A literature review. Journal of the American Academy of Nurse Practitioners, 17, 123-132.
11. Gupta, S., Rappaport, H.M., & Bennett, L.T. (1996). Polypharmacy among nursing home geriatric Medicaid recipients. Annals of Pharmacotherapy, 30, 946-950.
12. Hajjar, E.R., Cafiero, A.C., & Hanlon, J.T. (2007). Polypharmacy in elderly patients. American Journal of Geriatric Pharmacotherapy, 5, 345-351.
13. Hajjar, E.R., Hanlon, J.T., Sloane, R.J., Lindblad, C.I., Pieper, C.F., Ruby, C.M., et al. (2005). Unnecessary drug use in frail older people at hospital discharge. Journal of the American Geriatrics Society, 53, 1518-1523.
14. Hamdy, R.C., Moore, S.W., Whalen, K., Donnelly, J.P., Compton, R., Testerman, F., et al. (1995). Reducing polypharmacy in extended care. Southern Medical Journal, 88, 534-538.
15. Hanlon, J.T., Schmader, K.E., Koronkowski, M.J., Weinberger, M., Landsman, P.B., Samsa, G.P., et al. (1997). Adverse drug events in high risk older outpatients. Journal of the American Geriatrics Society, 45, 945-948.
16. Haque, R. (2009). ARMOR: A tool to evaluate polypharmacy in elderly persons. Annals of Long-Term Care, 17(6), 26-30.
17. Kane, R.L., Ouslander, J.G., Abrass, I.B., & Resnick, B. (2009). Essentials of clinical geriatrics (6th ed.). New York: McGraw-Hill.
18. Kaufman, D.W., Kelly, J.P., Rosenberg, L., Anderson, T.E., & Mitchell, A.A. (2002). Recent patterns of medication use in the ambulatory adult population of the United States: The Slone Survey. Journal of the American Medical Association, 287, 337-344.
19. Lechevallier-Michel, N., Molimard, M., Dartigues, J.F., Fabrigoule, C., & Fourrier-Réglat, A. (2005). Drugs with anticholinergic properties and cognitive performance in the elderly: Results from the PAQUID study. British Journal of Clinical Pharmacology, 59, 143-151.
20. Meyer, T.J., Van Kooten, D., Marsh, S., & Prochazka, A.V. (1991). Reduction of polypharmacy by feedback to clinicians. Journal of General Internal Medicine, 6, 133-136.
21. Michocki, R.J. (2001). Polypharmacy and principles of drug therapy. In A.M. Adelman & M.P. Daly (Eds.), 20 common problems in geriatrics (pp. 69-82). New York: McGraw-Hill.
22. Oeyen, S. (2007). About protocols and guidelines: It's time to work in harmony! Critical Care Medicine, 35, 292-293.
23. Rochon, P.A., & Gurwitz, J.H. (1997). Optimising drug treatment for elderly people: The prescribing cascade. BMJ, 315, 1096-1099.
24. Zarowitz, B.J., Stebelsky, L.A., Muma, B.K., Romain, T.M., & Peterson, E.L. (2005). Reduction of high-risk polypharmacy drug combinations in patients in a managed care setting. Pharmacotherapy, 25, 1636-1645.